Moody’s also affirmed the “Baa2” rating assigned to Baxter’s series 2012A and series 2007 bonds, affecting $41.8 million of debt.
The rating assignment and affirmation are based on a number of factors, including Baxter’s solid market position and improved margins through the first four months of fiscal year 2016.
The outlook is negative, reflecting Moody’s Investors Service’s belief that Baxter’s liquidity will remain constrained and below expectations.
More articles on healthcare finance:
Pioneer Health issues notice to close hospital after filing for bankruptcy
Cone Health sees operating margin fall as supply costs creep upward|
This week’s 5 must-reads for hospital CFOs
